Literature DB >> 16052518

HTLV-I viral escape and host genetic changes in the development of adult T cell leukemia.

Yoshitaka Furukawa1, Mitsutoshi Tara, Shuji Izumo, Kimiyoshi Arimura, Mitsuhiro Osame.   

Abstract

In the pathogenesis of adult T cell leukemia (ATL), an oncogenetic role of the human T cell lymphotropic virus type I (HTLV-I) Tax protein, viral escape from the host immune system, and host genetic changes have been proposed as contributory factors. We examined the premature stop codons in tax gene as one of the mutations that may lead to escape of HTLV-I from the cytotoxic T lymphocyte (CTL) response in HTLV-I carriers, to test whether a putative CTL escape mutant can emerge in the early stage of ATL development and whether HTLV-I infected cells with such a mutation can proliferate subsequently. We also examined deletion of cyclin-dependent kinase inhibitor 4 (INK4) genes and mutation of p53 gene in combination with changes in the HTLV-I genome in acute type ATL to test whether host genetic changes promoted the malignant transformation of ATL cells that carry putative CTL escape mutations. The premature stop codon in tax gene existed in many non-ATL HTLV-I carriers as a minor population but not in the commonest HTLV-I sequence of the individual. This minor population with a premature stop codon did not expand subsequently in 3 asymptomatic carriers tested. There were cases who had a mutation or deletion in HTLV-I who also have either deletion of INK4 genes or mutation in p53 gene. Our findings suggest that CTL escape mutation can occur at an early stage of ATL development, and that certain host genetic changes favor the development of the aggressive form of ATL. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16052518     DOI: 10.1002/ijc.21328

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  MHC signaling during social communication.

Authors:  James S Ruff; Adam C Nelson; Jason L Kubinak; Wayne K Potts
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 2.  Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art.

Authors:  Taylor H Schreiber; Luis Raez; Joseph D Rosenblatt; Eckhard R Podack
Journal:  Semin Immunol       Date:  2010-03-11       Impact factor: 11.130

3.  APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo.

Authors:  Jun Fan; Guangyong Ma; Kisato Nosaka; Junko Tanabe; Yorifumi Satou; Atsushi Koito; Simon Wain-Hobson; Jean-Pierre Vartanian; Masao Matsuoka
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

4.  Simian T Lymphotropic Virus 1 Infection of Papio anubis: tax Sequence Heterogeneity and T Cell Recognition.

Authors:  James M Termini; Diogo M Magnani; Helen S Maxwell; William Lauer; Iris Castro; Jerilyn Pecotte; Glen N Barber; David I Watkins; Ronald C Desrosiers
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

5.  Adaptive immune response to viral infections in the central nervous system.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Handb Clin Neurol       Date:  2014

6.  The HTLV-1 HBZ protein inhibits cyclin D1 expression through interacting with the cellular transcription factor CREB.

Authors:  Yunyun Ma; Shangen Zheng; Yuanyuan Wang; Wenqiao Zang; Min Li; Na Wang; Ping Li; Jing Jin; Ziming Dong; Guoqiang Zhao
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

7.  HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection.

Authors:  Chibueze Chioma Ezinne; Makoto Yoshimitsu; Yohann White; Naomichi Arima
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

8.  Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?

Authors:  Aileen G Rowan; Charles R M Bangham
Journal:  Leuk Res Treatment       Date:  2011-11-30

9.  Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.

Authors:  Lee Ratner; William Harrington; Xuan Feng; Christian Grant; Steve Jacobson; Ariela Noy; Joseph Sparano; Jeannette Lee; Richard Ambinder; Nancy Campbell; Michael Lairmore
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

10.  Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells.

Authors:  R S Hamamura; J H Ohyashiki; R Kurashina; C Kobayashi; Y Zhang; T Takaku; K Ohyashiki
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.